Skip to main content
. 2020 Nov 29;12(12):1164. doi: 10.3390/pharmaceutics12121164
API active pharmaceutical agents
CARPA complement activation-related pseudoallergy
CMAs critical material attributes
CPPs critical process parameters
CQAs critical quality attributes
D[3,2] surface-weighted mean
D[4,2] volume-weighted mean
DoE design of experiments
DS design space
EE encapsulation efficiency
GUV giant unilamellar vesicle
ICH International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
IV intravenous
ISO International Organisation for Standardisation
LUV large unilamellar vesicle
MUV medium-sized unilamellar vesicle
MVL multivesicular liposomes
PdI polydispersity index
PE phosphatidylethanolamine
PEG polyethylene glycol
QbD quality by design
QTPP quality target product profile
RA risk assessment
RES reticuloendothelial system
SSA specific surface area
SUV small unilamellar vesicle
Tm phase transition temperature